NEW YORK, NY--(Marketwire - March 4, 2008) - iiBIG (International Institute for Business Information & Growth) presents the 2nd Annual Pharmaceutical Sales & Marketing Executive Congress, scheduled for March 31 - April 1, 2008 in Bethesda, Maryland.

Drastic cutbacks at major pharmaceuticals continue and competition soars from generics. Social networks have entered the zone of physician and patient encounters. Advertising expenditures are being scrutinized for ROI. Product recalls and drug safety warnings pose new issues and responsibilities on drug marketers. Yet new marketing opportunities have opened up with the growth of multicultural segments, new technologies, media channels, and sales force optimization tools.

Sample key conference sessions:

--  Pharma Industry CMEs in Peril?
--  State of the Industry - Challenges and Opportunities in 2008 and
    Beyond
--  Beyond the DTC Decade: What are the Focus Areas for Brand Name Drugs
    and Generics?
--  ePharma Strategies - Future Opportunities for Cultivating
    Relationships
--  Winning Strategies to Cultivate Multicultural Consumers
--  Sharpening Your Edge by Enhancing Regulatory Know-How - Best Practices
    and The New Rules of the Game
--  Evidence based Medicine and Value to Pharma Marketing
--  Linking the Tablet PC-armed Field Force with Emerging e-Technology to
    Deliver the Right Message, to the right Prescriber - Right Now!
--  Communicating Risk - Key Issues at Hand
    

Executive Speaking Faculty Includes:

--  Hon. Gene Green (D-TX), Member, Health Subcommittee - Energy &
    Commerce Committee, U.S. House of Representatives
--  Kristin Rand, JD, Director of Education Strategy, Professional
    Education Support, Wyeth Pharmaceuticals
--  Lori Ryan, Executive Director, Head of Finance CVM Sales Force,
    Novartis Pharmaceuticals
--  Paul J. Savidge, VP, Global Labeling & Compliance, Bristol-Myers
    Squibb
--  Liliana A. Gil, Worldwide Director of Marketing Services & Hispanic
    Strategy Lead, Johnson & Johnson
--  Ellen Shapiro, Director, Division of Communications, Center for Drug
    Evaluation and Research (CDER), FDA
--  David Lampinski, Associate Director, Commercial Analytics, Sepracor
    Inc.
--  Jeannie Miller, Managed Markets, Jazz Pharmaceuticals
--  Glenn Byrd, VP, Regulatory Affairs, MedImmune
--  Jan Malek, Director, IBSG-Life Sciences, Cisco Systems
--  John S. Lenart, Senior Brand Director, Arestin®, OraPharma, Inc.
    

For Conference Updates and Complete Speaker Roster: http://www.iibig.com/P0802.